一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Thrombosis and Haemostasis >>article
Journal of Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis

IF: 5.5
Download PDF

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms

Published:11 April 2006 DOI: 10.1111/j.1538-7836.2006.01986.x PMID: 16961594
F. DENTALI, W. AGENO, M. CROWTHER

Abstract

Summary. Background: An excessive anticoagulant effect because of coumarins is frequently encountered. Objective: To review available literature on the management of warfarin-associated coagulopathy and to propose evidence-based treatment algorithms. Methods: Data sources were Medline and Embase. Papers published between 1966 and December 2005 describing randomized trials or prospective cohort studies evaluating treatments for coumarin-associated coagulopathy were abstracted. Results: Low dose oral vitamin K rapidly and reliably returns the international normalized ratio (INR) to the usual therapeutic range in non-bleeding patients. Simple withholding of acenocumarol results in rapid correction of its anticoagulant effect. The impact of oral vitamin K on phenprocumon-associated coagulopathy cannot be determined from available literature. Intravenous vitamin K and coagulation factors should be given to patients with major or life-threatening hemorrhage. The optimal dose and type of coagulation factor is not known. Conclusions: Vitamin K therapy is an effective treatment for INR prolongation in patients with coumarin-associated coagulopathy; coagulation factor replacement is required, in addition, in patients with major bleeding or with indication for immediate correction of their INR. Clinical trials powered to detect differences in rates of bleeding and thrombosis are now required to determine if vitamin K reduces the risk of bleeding without causing thrombosis in non-bleeding patients with prolonged INR.

Substances (5)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Coumarin 91-64-5 C9H6O2 901 suppliers $5.00-$25334.40
Warfarin 81-81-2 C19H16O4 227 suppliers $19.00-$2055.90
ACENOCOUMAROL 152-72-7 C19H15NO6 151 suppliers $34.00-$1487.03
PHENPROCOUMON 435-97-2 C18H16O3 98 suppliers $44.00-$2475.00
VITAMIN K1 12001-79-5 C31H46O2 75 suppliers Inquiry

Similar articles

IF:2.5

Effectiveness of prednisolone in complex regional pain syndrome treatment: A systematic narrative review.

Pain Practice Sang Gyu Kwak, Yoo Jin Choo,etc Published: 1 March 2022
IF:3.4

Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis

Advances in Therapy Sofia Tejada, Raquel Martinez-Reviejo,etc Published: 25 July 2022
IF:8

Treatment of sulfolane in groundwater: A critical review

Journal of Environmental Management My Dinh , Seyfollah Gilak Hakimabadi ,etc Published: 1 June 2020
宜宾县| 武安市| 齐河县| 平顺县| 娄底市| 博爱县| 常宁市| 淮滨县| 城市| 灵石县| 嘉峪关市| 皋兰县| 岱山县| 兴宁市| 临泽县| 盘锦市| 曲水县| 遂川县| 普定县| 平利县| 宝坻区| 方正县| 武城县| 高邮市| 集安市| 长治市| 扬中市| 商南县| 六盘水市| 祁连县| 江北区| 称多县| 潮州市| 福安市| 金平| 徐闻县| 怀宁县| 黄龙县| 庐江县| 双牌县| 波密县|